Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

× No keyword cloud information.

8 in total

1. Medical management of inflammatory bowel disease among Canadian gastroenterologists.

Authors: J Jones; R Panaccione; M L Russell; R Hilsden
Journal: Can J Gastroenterol Date: 2011-10 Impact factor: 3.522

Review 2. Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors: D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal: Can J Gastroenterol Date: 2009-03 Impact factor: 3.522

3. Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists.

Authors: Hilbert S de Vries; Martijn G H van Oijen; Rieke J B Driessen; Elke M G J de Jong; Marjonne C W Creemers; Wietske Kievit; Dirk J de Jong
Journal: Br J Clin Pharmacol Date: 2011-01 Impact factor: 4.335

4. Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.

Authors: Christopher W Teshima; Adrienne Thompson; LeRose Dhanoa; Levinus A Dieleman; Richard N Fedorak
Journal: Can J Gastroenterol Date: 2009-05 Impact factor: 3.522

Review 5. Review and clinical perspectives for the use of infliximab in ulcerative colitis.

Authors: R Panaccione; R N Fedorak; G Aumais; Edmond-Jean Bernard; C N Bernstein; A Bitton; K Croitoru; L A Dieleman; R Enns; B G Feagan; D Franchimont; G R Greenberg; Anne-Marie Griffiths; J K Marshall; P Pare; S Patel; R Penner; C Render; E Seidman; A Hillary Steinhart
Journal: Can J Gastroenterol Date: 2008-03 Impact factor: 3.522

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

1. Medical management of inflammatory bowel disease among Canadian gastroenterologists.

Review 2. Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

3. Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists.

4. Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.

Review 5. Review and clinical perspectives for the use of infliximab in ulcerative colitis.

Review 6. The place of interventional radiology in Crohn disease in children.

Review 7. Use of the tumor necrosis factor-blockers for Crohn's disease.

Review 8. Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review.